White matter lesions in dementia: An MRI study on blood-brain barrier dysfunction

Dementia and Geriatric Cognitive Disorders

Volumn 11, Issue 5, 2000, Pages 263-267

  Bronge, Lena ^a   Wahlund, Lars Olof ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood brain barrier; Contrast enhancement; Magnetic resonance imaging; White matter lesions

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DEMENTIA; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0033844010     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017248     Document Type: Article

References (26)

1. Meyer JS, Kawamura J, Terayama Y: Review article: White matter lesions in the elderly. J Neurol Sci 1992;110:1-7.
2. Golomb J, Kluger A, Gianutsos J, Ferris S, de Leon MJ, George Ajax E: Nonspecific leukoencephalopathy associated with aging. Neuroimaging Clin North Am 1995;5:33-44.
3. Baloh R, Vinters H: White matter lesions and disequilibrium in older people. II. Clinicopathologic correlation. Arch Neurol 1995;152: 975-981.
4. Mirsen TR, Lee DH, Wong CJ, Diaz JF, Fox AJ, Hachinski VC, Merskey H: Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch Neurol 1991;48:1015-1021.
5. Bowen BC, Barker WW, Loewenstein DA, Sheldon J, Duara R: MR signal abnormalities in memory disorder and dementia. AJNR 1990;11:283-290.
6. McDonald W, Ranga K, Krishnan R, Doraiswamy M, Figiel G, Husain M, Boyko O, Heyman A: Magnetic resonance findings in patients with early-onset Alzheimer's disease. Biol Psychiatry 1991;29:799-810.
7. Janota I, Mirsen T, Hachinski VC, Lee DH, Merskoy H: Neuropathologic correlates of leuko-araiosis. Arch Neurol 1989;46:1124-1128.
8. Scheltens P. Barkhof F, Leys D, Wolters E, Ravid R, Kamphorst W: Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995;45:883-888.
9. Pollay M, Roberts PA: Blood-brain barrier: A definition of normal and altered function. Neurosurgery 1980;6:675-685.
10. Blennow K, Wallin A, Uhlemann C, Gottfries CG: White-matter lesions on CT in Alzheimer patients: Relation to clinical symptomatology and vascular factors. Acta Neurol Scand 1991; 83:187-193.
11. Mecocci P, Parnetti L, Reboldi GP, Santucci C, Gaiti A, Ferri C, Gemini I, Romagnoli M, Cadini D, Senin U: Blood-brain barrier in a geriatric population: Barrier function in degenerative and vascular dementias. Acta Neurol Scand 1991;84:210-213.
12. Pantoni L, Inzitari D, Pracucci G, Lolli F, Giordano G, Bracco L, Amaducci L: Cerebrospinal fluid proteins in patients with leucoaraiosis: Possible abnormalities in blood-brain barrier function. J Neurol Sci 1993;115:125-131.
13. Erkinjuntti T, Sulkava R, Palo J, Ketonen L: White matter low attenuation on CT in Alzheimer's disease. Arch Gerontol Geriatr 1989; 8:95-104.
14. Wallin A, Blennow K, Fredman P, Gottfries CG, Karlsson I, Svennerholm L: Blood brain barrier function in vascular dementia. Acta Neurol Scand 1990;81:318-322.
15. Schmiedl U, Kenney J, Maravilla K: MRI of blood-brain barrier permeability in astrocytic gliomas: Application of small and large molecular weight contrast media. Magn Reson Med 1991;22:288-292.
16. Hayakawa K, Yamashita K, Mitsumori M, Nakano Y: In vivo quantification of the blood-brain harrier injury using magnetic resonance enhancement. Invest Radiol 1990;25:S80-S81.
17. Rhine W, Benaron D, Enzman D, Chung C, Gonzales-Mendez R, Sayre J, Stevenson D: Gd-DTPA MR detection of blood-brain barrier opening in rats after hyperosmotic shock. J Compul Assist Tomogr 1993;17:563-566.
18. Tofts PS: Optimal detection of blood-brain barrier detects with Gd-DTPA MRI - The influences of delayed imaging and optimized repetition time. Magn Reson Imag 1996;14: 373-380.
19. Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langstrom G, Skoog I, Svennerholm L, Wikkelsö C: Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol 1993;33:129-133.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
21. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennet DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culehras A, Korczyn AD. Bogousslavsky J, Hartmann A, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
22. Tomimoto H, Akiguchi I, Suenaga T, Nishimura M, Wakita H, Nakamura S, Kimura J: Alterations of blood-brain barrier and glial cells in white matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke 1996;27: 2069-2074.
23. Blennow K, Wallin A, Fredman P, Karlsson I, Goltfries CG, Svennerholm L: Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand 1990;81:323-326.
24. 68Ga)-EDTA and positron emission tomography. J Cerebr Blood Flow Metab 1987;7:1-8.
25. Caserta M, Caccioppo D, Lapin G, Ragin A, Groothuis D: Blood-brain barrier integrity in Alzheimer's disease patients and elderly control subjects. J Neuropsychiatry Clin Neurosci 1998;10:78-84.
26. Perlmutter L, Chang Chui H: Microangiopathy, the vascular basement membrane and Alzheimer's disease: A review. Brain Res Bull 1990;24:677-686.